These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4014336)

  • 1. Analysis of 2136 genetic amniocenteses: experience of a single physician.
    Hanson FW; Tennant FR; Zorn EM; Samuels S
    Am J Obstet Gynecol; 1985 Jun; 152(4):436-43. PubMed ID: 4014336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amniocentesis before 15 weeks' gestation: outcome, risks, and technical problems.
    Hanson FW; Zorn EM; Tennant FR; Marianos S; Samuels S
    Am J Obstet Gynecol; 1987 Jun; 156(6):1524-31. PubMed ID: 3591865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasonography-guided early amniocentesis in singleton pregnancies.
    Hanson FW; Happ RL; Tennant FR; Hune S; Peterson AG
    Am J Obstet Gynecol; 1990 Jun; 162(6):1376-81; discussion 1381-3. PubMed ID: 2193512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonography-guided amniocentesis in singleton pregnancies: a review of the first 1,000 cases.
    Ajayi GO
    Clin Exp Obstet Gynecol; 2011; 38(4):405-7. PubMed ID: 22268286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplacental amniocentesis: is it really a higher-risk procedure?
    Giorlandino C; Mobili L; Bilancioni E; D'Alessio P; Carcioppolo O; Gentili P; Vizzone A
    Prenat Diagn; 1994 Sep; 14(9):803-6. PubMed ID: 7845887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic amniocentesis: impact of placental position upon the risk of pregnancy loss.
    Crane JP; Kopta MM
    Am J Obstet Gynecol; 1984 Dec; 150(7):813-6. PubMed ID: 6391172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedure-related fetal losses in transplacental versus nontransplacental genetic amniocentesis.
    Bombard AT; Powers JF; Carter S; Schwartz A; Nitowsky HM
    Am J Obstet Gynecol; 1995 Mar; 172(3):868-72. PubMed ID: 7892877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis.
    Kong CW; Leung TN; Leung TY; Chan LW; Sahota DS; Fung TY; Lau TK
    Prenat Diagn; 2006 Oct; 26(10):925-30. PubMed ID: 16838383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the significance of discolored amniotic fluid detected at midtrimester amniocentesis.
    Zorn EM; Hanson FW; Greve LC; Phelps-Sandall B; Tennant FR
    Am J Obstet Gynecol; 1986 Jun; 154(6):1234-40. PubMed ID: 3717234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up of 2000 second-trimester amniocenteses.
    Crandall BF; Howard J; Lebherz TB; Rubinstein L; Sample WF; Sarti D
    Obstet Gynecol; 1980 Nov; 56(5):625-8. PubMed ID: 7432734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. The Canadian Early and Mid-trimester Amniocentesis Trial (CEMAT) Group.
    Lancet; 1998 Jan; 351(9098):242-7. PubMed ID: 9457093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic amniocentesis in multiple pregnancy.
    Tóth-Pál E; Papp C; Beke A; Bán Z; Papp Z
    Fetal Diagn Ther; 2004; 19(2):138-44. PubMed ID: 14764958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual risk of fetal loss following routine second trimester amniocentesis: a controlled study of 20,460 cases.
    Kozlowski P; Knippel A; Stressig R
    Ultraschall Med; 2008 Apr; 29(2):165-72. PubMed ID: 17602371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two years of mid-trimester amniocentesis in Johannesburg.
    Kromberg J; Bernstein R; Jenkins T; Bernstein J; Goudie EG; Sneider P
    S Afr Med J; 1980 Jun; 57(25):1031-9. PubMed ID: 7190735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic mid trimester amniocentesis: how safe?
    Seeds JW
    Am J Obstet Gynecol; 2004 Aug; 191(2):607-15. PubMed ID: 15343248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy loss rate following routine genetic amniocentesis at Wellington Hospital.
    Sangalli M; Langdana F; Thurlow C
    N Z Med J; 2004 Apr; 117(1191):U818. PubMed ID: 15107887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal loss rate after second trimester amniocentesis at different gestational age.
    Saltvedt S; Almström H
    Acta Obstet Gynecol Scand; 1999 Jan; 78(1):10-4. PubMed ID: 9926885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midtrimester amniocentesis: is it safe? A single centre controlled prospective study of 517 consecutive amniocenteses.
    Sant-Cassia LJ; MacPherson MB; Tyack AJ
    Br J Obstet Gynaecol; 1984 Aug; 91(8):736-44. PubMed ID: 6380566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midtrimester amniocentesis. An analysis of 923 cases with neonatal follow-up.
    Cruikshank DP; Varner MW; Cruikshank JE; Grant SS; Donnelly E
    Am J Obstet Gynecol; 1983 May; 146(2):204-11. PubMed ID: 6189400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Outcome of pregnancy following amniocentesis in the prenatal diagnosis of genetic birth defects].
    Schlensker KH; Citoler P; Bolte A
    Geburtshilfe Frauenheilkd; 1984 Mar; 44(3):137-45. PubMed ID: 6562979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.